Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04509115 · ClinicalTrials.gov registry record
Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 1,709
- Enrollment target
NCT04509115: Completed study, sponsored by Yale University.
NCT04509115 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 1,709 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04509115 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 1,709 participants
- Enrollment target
Study Summary
This study will characterize patient pain and opioid use after an initial opioid prescription for acute pain.
Primary Outcome
Number of days using any opioid medications
Interventions
- DRUG Short-acting opioid prescription for acute pain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,709 participants |
| Start Date | 2020-09-11 |
| Est. Completion | 2023-11-30 |
What the finished NCT04509115 record still lists
NCT04509115 is an observational study that tracks outcomes without assigning an intervention. Its 1,709 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Short-acting opioid prescription for acute pain is the first listed.
NCT04509115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04509115 about?
NCT04509115 is a clinical study titled "Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations". This study will characterize patient pain and opioid use after an initial opioid prescription for acute pain.
What is the current status of trial NCT04509115?
This trial is currently completed. The enrollment target is 1,709 participants. The study started on 2020-09-11. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT04509115?
The interventions under investigation include: Short-acting opioid prescription for acute pain (DRUG).
Who is sponsoring clinical trial NCT04509115?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI